Antiatherogenic Effect of Combination Therapy Calcium Channel Blocker with Renin-Angiotensin System Inhibitor on Hypertensive Patients

Antiatherogenic Effect of Combination Therapy Calcium Channel Blocker with Renin-Angiotensin System Inhibitor on Hypertensive Patients - AECOCAR Study

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000003474

Enrollment

Registered

2010-05-01

Start date

2010-05-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypertension

Interventions

ARB, ACE, Ca blocker

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Hypertension Systolic blood pressure >140 Diastolic blood pressure >90

Exclusion criteria

Exclusion criteria: none

Design outcomes

Primary

Measure	Time frame
Changing in blood pressure Changing in plaque	—

Countries

Japan

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026